This article was originally published in The Gray Sheet
Executive SummaryMansfield, Massachusetts-based Kendall International subsidiary, which supplies wound care, vascular therapy, urological care, anesthetic care and incontinence care products, files statement with the Securities and Exchange Commission related to a proposed offering of $100 mil. in senior subordinated notes due 2003. Net proceeds, "together with additional borrowings" under an amended bank credit agreement, will be used to redeem all of the company's outstanding 10%/12% senior subordinated notes due 2000 "in the principal amount of $195.7 mil." Merrill Lynch & Co. and Citicorp Securities Markets are underwriting.
You may also be interested in...
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.